| Description | MIEN1 is a small (12 kDa) membrane bound protein found in a variety of human tumours (Evans et al., 2006). Its main function is to induce cell invasion and it may be involved in metastasis (Dasgupta et al., 2011; Dasgupta and Vishwanatha, 2007; Katz et al., 2010). |
| Expression | MIEN1 is almost exclusively expressed in human tumours, with the notable exception of Leydig cells in testes (Evans et al., 2006). |
| Localisation | MIEN1 protein is membrane bound and its stability depends on its localization (our unpublished observations). MIEN1 contains a CVIL amino acid sequence in the C-terminal, which fits the prenylation motif CaaX (Evans et al., 2006). Based on several physical properties, such as size, flexibility, membrane buried preference, and presence of leucine as the X residue, MIEN1 is predicted to be geranylgeranylated in vivo by GGTI enzyme, resulting in the addition of 20-carbon isoprenoid moiety. |
| |  |
| |
| | With permission by Hsu et al. (Hsu et al., 2012). |
| |
| Function | The MIEN1 sequence EATYLELASAVKEQYPGIEI conforms to a prototypical immuno-receptor tyrosine-based activation motif (ITAM). ITAMs, such as this of C35 rely on Syk protein kinase for their signaling capacities (Katz et al., 2010). The most commonly reported consequence of MIEN1 over-expression is the induction of cell motility and invasion (Dasgupta et al., 2011; Katz et al., 2010). High levels of MIEN1 expression lead to epithelial to mesenchymal transition in breast cell lines (Katz et al., 2011a). However, intermediate levels lead to a cancer phenomenon rarely observed in experimental models, collective invasion (Katz et al., 2011b). |
| Homology | MIEN1 is very highly conserved among six higher eukaryotic species (identities >77%) but does not seem to have orthologues in microbial organisms (Evans et al., 2006). MIEN1 contains an ITAM motif which is prevalent in immune receptors as well as oncogenic viruses. |
| Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. |
| Kauraniemi P, Kuukasjarvi T, Sauter G, Kallioniemi A. |
| Am J Pathol. 2003 Nov;163(5):1979-84. |
| PMID 14578197 |
| |
| Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study. |
| Einarsdottir K, Rosenberg LU, Humphreys K, Bonnard C, Palmgren J, Li Y, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedren S. |
| Breast Cancer Res. 2006;8(6):R67. |
| PMID 17132159 |
| |
| C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. |
| Evans EE, Henn AD, Jonason A, Paris MJ, Schiffhauer LM, Borrello MA, Smith ES, Sahasrabudhe DM, Zauderer M. |
| Mol Cancer Ther. 2006 Nov;5(11):2919-30. |
| PMID 17121940 |
| |
| Role of C17orf37/MGC14832 in prostate cancer cell proliferation and migration. |
| Dasgupta S, Vishwanatha JK. |
| FASEB J. 2007; 21(5):A289-b. |
| |
| Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells. |
| Dasgupta S, Wasson LM, Rauniyar N, Prokai L, Borejdo J, Vishwanatha JK. |
| Oncogene. 2009 Aug 13;28(32):2860-72. doi: 10.1038/onc.2009.145. Epub 2009 Jun 8. |
| PMID 19503095 |
| |
| A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. |
| Katz E, Dubois-Marshall S, Sims AH, Faratian D, Li J, Smith ES, Quinn JA, Edward M, Meehan RR, Evans EE, Langdon SP, Harrison DJ. |
| Br J Cancer. 2010 Jul 27;103(3):401-10. doi: 10.1038/sj.bjc.6605763. Epub 2010 Jul 13. |
| PMID 20628393 |
| |
| Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis. |
| Dasgupta S, Cushman I, Kpetemey M, Casey PJ, Vishwanatha JK. |
| J Biol Chem. 2011 Jul 22;286(29):25935-46. doi: 10.1074/jbc.M111.254599. Epub 2011 May 31. |
| PMID 21628459 |
| |
| An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer. |
| Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, Meehan RR, Harrison DJ. |
| PLoS One. 2011a Feb 15;6(2):e17083. doi: 10.1371/journal.pone.0017083. |
| PMID 21347235 |
| |
| An analytical approach differentiates between individual and collective cancer invasion. |
| Katz E, Verleyen W, Blackmore CG, Edward M, Smith VA, Harrison DJ. |
| Anal Cell Pathol (Amst). 2011b;34(1-2):35-48. doi: 10.3233/ACP-2011-0003. |
| PMID 21483102 |
| |
| Solution structure of the oncogenic MIEN1 protein reveals a thioredoxin-like fold with a redox-active motif. |
| Hsu CH, Shen TL, Chang CF, Chang YY, Huang LY. |
| PLoS One. 2012;7(12):e52292. doi: 10.1371/journal.pone.0052292. Epub 2012 Dec 20. |
| PMID 23284973 |
| |